![]() ![]() However, those who received the J&J/Janssen vaccine are now eligible for a booster shot if they received their initial dose at least 2 months ago. At this time, the CDC is not recommending an additional dose for patients who received the Johnson & Johnson/Janssen vaccine, even if they are immunocompromised. This recommendation only applies to individuals who received an mRNA vaccine, in other words, the Pfizer or Moderna vaccine. Active treatment with immune-suppressing medications, including high-dose corticosteroids, chemotherapy, tumor necrosis factor (TNF) inhibitors, and other biologic agents that suppress or modulate the immune system.Moderate or severe primary immunodeficiency.Previous solid organ transplant (such as a kidney or liver transplant) All COVID-19 vaccines available in Australia have been provisionally approved by the Therapeutic Goods Administration (TGA), meaning they have met rigorous standards for safety, quality and efficacy.Previous stem cell transplant or CAR T-cell therapy.This includes those with the following conditions: The CDC recommends a third dose for patients ages 5 and up who are moderately or severely immunocompromised. Read additional CDC guidance for the immunocompromised, including information for those receiving J&J vaccines and boosters. If you are between 5 and 11 years old, you are eligible for a Pfizer monovalent booster if you completed your 3-dose primary series of Pfizer at least 3 months ago. Those who are 18+ years old are eligible for a Pfizer or Moderna bivalent booster. Those who are between 12 and 17 years old are eligible for Pfizer bivalent booster only at this time. If you are immunocompromised, are 12 years of age or older, and have completed your primary series or your most recent booster at least 2 months ago, you are eligible for a bivalent booster. ![]() If you received the Johnson & Johnson/Janssen vaccine at least 2 months ago and are 18 years old or older, you are eligible to receive a bivalent booster shot. ![]() For people ages 5-11 years old, only the Pfizer monovalent booster is approved at this time.
0 Comments
Leave a Reply. |